Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Sourindra Maiti"'
Autor:
Shan Zong, Tiejuan Mi, Leo G Flores, Amir Alpert, Simon Olivares, Krina Patel, Sourindra Maiti, George Mcnamara, Laurence J N Cooper, Hiroki Torikai
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0228112 (2020)
Neoantigens can be predicted and in some cases identified using the data obtained from the whole exome sequencing and transcriptome sequencing of tumor cells. These sequencing data can be coupled with single-cell RNA sequencing for the direct interro
Externí odkaz:
https://doaj.org/article/4eec5f019e52437b91fb808806951b5d
Autor:
Niannian Ji, Neelam Mukherjee, Edwin E. Morales, Maggie E. Tomasini, Vincent Hurez, Tyler J. Curiel, Getahun Abate, Dan F. Hoft, Xiang-Ru Zhao, Jon Gelfond, Sourindra Maiti, Laurence J.N. Cooper, Robert S. Svatek
Publikováno v:
OncoImmunology, Vol 8, Iss 8 (2019)
Background: Intravesical bacillus Calmette-Guérin (BCG) is the gold standard immunologic agent for treating patients with high-grade non-muscle invasive bladder cancer (NMIBC). Nevertheless, relapse rates remain high and BCG unresponsive NMIBC often
Externí odkaz:
https://doaj.org/article/6d77a692e2c14502a3870a79efe0d2ef
Autor:
Radhika Thokala, Simon Olivares, Tiejuan Mi, Sourindra Maiti, Drew Deniger, Helen Huls, Hiroki Torikai, Harjeet Singh, Richard E Champlin, Tamara Laskowski, George McNamara, Laurence J N Cooper
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0159477 (2016)
Adoptive immunotherapy infusing T cells with engineered specificity for CD19 expressed on B- cell malignancies is generating enthusiasm to extend this approach to other hematological malignancies, such as acute myelogenous leukemia (AML). CD123, or i
Externí odkaz:
https://doaj.org/article/6a199d18b6234618b7b0ad5ae27e1c1f
Autor:
Harjeet Singh, Matthew J Figliola, Margaret J Dawson, Simon Olivares, Ling Zhang, Ge Yang, Sourindra Maiti, Pallavi Manuri, Vladimir Senyukov, Bipulendu Jena, Partow Kebriaei, Richard E Champlin, Helen Huls, Laurence J N Cooper
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e64138 (2013)
Adoptive transfer of T cells expressing a CD19-specific chimeric antigen receptor (CAR) is being evaluated in multiple clinical trials. Our current approach to adoptive immunotherapy is based on a second generation CAR (designated CD19RCD28) that sig
Externí odkaz:
https://doaj.org/article/9e74176212bd40a58bea38aeed27eae3
Autor:
Bipulendu Jena, Sourindra Maiti, Helen Huls, Harjeet Singh, Dean A Lee, Richard E Champlin, Laurence J N Cooper
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e57838 (2013)
Clinical trials targeting CD19 on B-cell malignancies are underway with encouraging anti-tumor responses. Most infuse T cells genetically modified to express a chimeric antigen receptor (CAR) with specificity derived from the scFv region of a CD19-sp
Externí odkaz:
https://doaj.org/article/88ac35af49654cb9ab652e8bcc808407
Autor:
Laurence J.N. Cooper, Laszlo Radvanyi, Patrick Hwu, Luis M. Vence, Richard E. Champlin, Brian Rabinovich, Helen Huls, Chantale Bernatchez, Sourindra Maiti, Minying Zhang
PDF file, 111K, Supplementary Table S1. Samples from 14 patients that received autologous TILs were studied. Supplementary Table S2.TCR Vα primers (the first 50 nt) and probes (the last 50 nt)used for DTEA analysis. Supplementary Table S3. TCR Vβ p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c1a55d7e367244eccf8a599dbaf554
https://doi.org/10.1158/1078-0432.22452699
https://doi.org/10.1158/1078-0432.22452699
Autor:
Laurence J.N. Cooper, Laszlo Radvanyi, Patrick Hwu, Luis M. Vence, Richard E. Champlin, Brian Rabinovich, Helen Huls, Chantale Bernatchez, Sourindra Maiti, Minying Zhang
Purpose: T-cell receptor (TCR) variable Vα and Vβ gene diversity is a surrogate biomarker for the therapeutic potential of adoptive immunotherapy and cellular immunity. Therefore, creating a straightforward, rapid, sensitive, and reliable method to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208520aa785b7869cea7f96fa21be904
https://doi.org/10.1158/1078-0432.c.6522561
https://doi.org/10.1158/1078-0432.c.6522561
Autor:
Laurence J.N. Cooper, Laszlo Radvanyi, Patrick Hwu, Luis M. Vence, Richard E. Champlin, Brian Rabinovich, Helen Huls, Chantale Bernatchez, Sourindra Maiti, Minying Zhang
PDF file, 264K, Supplementary Fig. S1. TCR Va and Vb gene expression in total RNA from TILs patient 303 and patient 232. Supplementary Fig S2. Global measurement of TCR Va (A-C) and TCR Vb (D-F) gene expression in patient 231 including in vitro rapid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a56ec712830da2312c52584c1a0de1
https://doi.org/10.1158/1078-0432.22452702.v1
https://doi.org/10.1158/1078-0432.22452702.v1
Autor:
Laurence J.N. Cooper, Richard E. Champlin, Dean A. Lee, Partow Kebriaei, Sourindra Maiti, Tiejuan Mi, Kirsten Switzer, Simon Olivares, Helen Huls, Margaret J. Dawson, Matthew J. Figliola, Harjeet Singh
Supplementary Figure 1 from Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4076b52e651b57eeefa493e57eeb308
https://doi.org/10.1158/0008-5472.22388582
https://doi.org/10.1158/0008-5472.22388582
Publikováno v:
Photodermatology, Photoimmunology & Photomedicine. 38:158-168
BACKGROUND/PURPOSE Accurate assessment of malignant T-cell clones in patients with leukemic cutaneous T-cell lymphoma (L-CTCL) is crucial for diagnosis, treatment, and monitoring disease. Although multiple approaches to quantitate malignant T-cell cl